Risperdal Recall

July 2011
Pharmaceutical Representative;Jul2011, Vol. 41 Issue 7, p9
The article discusses the move of Ortho-McNeil-Janssen Pharmaceuticals Inc., a subsidiary of Johnson & Johnson, to initiate a voluntary recall of its antipsychotic medication Risperdal due to unsual odor.


Related Articles

  • Retin-A update. Lebowitz, L. // Self;Feb92, Vol. 14 Issue 2, p26 

    Reports that now that Ortho Pharmaceutical's 17-year patent for Retin-A has run out, competitors are racing to bring name brands of tretinoin, the generic term for the active ingredient in Retin-A, to market. Stumbling blocks; Advanced Polymer Systems may be Ortho's biggest competitor; Ironies.

  • Refillable compact dispenses daily dose. Abrams, Bernard // Packaging Digest;Feb2000, Vol. 37 Issue 2, p37 

    Reports on the packaging of oral contraceptives manufactured by Raritan, New Jersey-based Ortho-McNeil Inc. Features of the Ortho Personal Pak introduced in January 2000; Reversal of normal procedure for Dialpak; Advantages of having reusable dispensers.

  • J&J unleashing $50 mil to launch Renova skin cream. Sloan, Pat // Advertising Age;6/3/1996, Vol. 67 Issue 23, p3 

    Relates that Johnson & Johnson's Ortho Pharmaceuticals unit will spend $50 million in marketing money on its prescription skin cream Renova. A print campaign for the product approved by the United States Food & Drug Administration; Approval for a television advertisement expected to follow; A...

  • New kid in town. Korman, Lorraine // American Salon;Jun96, Vol. 119 Issue 6, p32 

    Features the wrinkle-fighter extant Renova from Ortho Pharmaceutical Corp., approved by the Food and Drug Administration. Tretinoin as active ingredient; Lessening of dryness and reddening side effects.

  • Ortho's $45 million expansion to consolidate oral-contraceptives operation in Manati. M.M. // Caribbean Business;6/26/2003, Vol. 31 Issue 25, p16 

    Focuses on the expansion of Ortho Pharmaceuticals in Puerto Rico. Number of additional jobs; Consolidation of oral contraceptives with manufacturing operations.

  • Ortho Tri-Cyclen--`two thumbs up'. Dickinson, James G. // Medical Marketing & Media;Feb99, Vol. 34 Issue 2, p36 

    Reports on the United States Food & Drug Administration's (FDA) endorsement of Ortho Pharmaceuticals Corp.'s advertisement for its Ortho Tri-Cyclen contraceptive.

  • Youth serum. Murray, Mary // Vogue;Mar96, Vol. 186 Issue 3, p424 

    Focuses on Ortho Pharmaceutical's Renova, a US Food & Drug Administration- (FDA) approved wrinkle fighter. Active ingredient of the skin cream; Benefits of the anti-wrinkle cream; Side effects.

  • Tapentadol Immediaterelease Tablets C-II (Nucyntaâ„¢). Elliott, William T.; Chan, James // Internal Medicine Alert;8/15/2009, Vol. 31 Issue 15, p117 

    The article offers information about a new opioid analgesic called Tapentadol released by Pricara, a part of the Ortho-McNeil-Janssen Pharmaceuticals Inc. and discusses a study regarding the effectiveness of the drug.

  • Topamax warnings stronger.  // Drug Utilization Review;Nov2001, Vol. 17 Issue 11, p8 

    Reports on the strengthened warning and precautions sections in the label of anticonvulsants Topamax tablets and Sprinkle capsules from Ortho-McNeil company. Indications; Side effects; Treatment of side effects.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics